DF/HCC Program Affiliation

Leukemia, Co-Leader
Prostate Cancer

DF/HCC Associations

Institutional Representative for BIDMC, Executive Committee
Member, Center Scientific Council

Research Abstract

The Pandolfi laboratory focuses on elucidating the molecular mechanisms and the genetics underlying the pathogenesis of leukemias, lymphomas and solid tumors as well as in modeling these cancers in the mouse. Dr. Pandolfi and colleagues have characterized the function of the fusion oncoproteins and the genes involved in the chromosomal translocations of acute promyelocytic leukemia (APL), as well as of major tumor suppressors such PTEN and p53 and novel proto-oncogenes such POKEMON. The elucidation of the molecular basis underlying APL pathogenesis has led to the development of novel and effective therapeutic strategies. As a result of these efforts, APL is now considered a curable disease. Novel therapeutic concepts have emerged from this work that are currently being tested in clinical trials.

Publications

View All Publications